91 related articles for article (PubMed ID: 8057666)
1. Essential role of c-myc in ara-C-induced differentiation of human erythroleukemia cells.
Baker SJ; Pawlita M; Leutz A; Hoelzer D
Leukemia; 1994 Aug; 8(8):1309-17. PubMed ID: 8057666
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by 1,25 dihydroxyvitamin D3 of c-myc down-regulation and DNA fragmentation in cytosine arabinoside-induced erythroid differentiation of K562 cells.
Moore DC; Carter DL; Studzinski GP
J Cell Physiol; 1992 Jun; 151(3):539-48. PubMed ID: 1295901
[TBL] [Abstract][Full Text] [Related]
3. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
[TBL] [Abstract][Full Text] [Related]
4. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
5. Terminal erythroid differentiation in the K-562 cell line by 1-beta-D-arabinofuranosylcytosine: accompaniment by c-myc messenger RNA decrease.
Bianchi Scarrà GL; Romani M; Coviello DA; Garrè C; Ravazzolo R; Vidali G; Ajmar F
Cancer Res; 1986 Dec; 46(12 Pt 1):6327-32. PubMed ID: 3536078
[TBL] [Abstract][Full Text] [Related]
6. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
Chen YL; Wu RT
Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
[TBL] [Abstract][Full Text] [Related]
7. Effects of 1-beta-D-arabinofuranosylcytosine and phorbol ester on differentiation of human K562 erythroleukemia cells.
Watanabe T; Mitchell T; Sariban E; Sabbath K; Griffin J; Kufe D
Mol Pharmacol; 1985 Jun; 27(6):683-8. PubMed ID: 3858662
[TBL] [Abstract][Full Text] [Related]
8. Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562.
Tonini GP; Radzioch D; Gronberg A; Clayton M; Blasi E; Benetton G; Varesio L
Cancer Res; 1987 Sep; 47(17):4544-7. PubMed ID: 3476195
[TBL] [Abstract][Full Text] [Related]
9. Coordinate change of c-myc, transferrin receptor and H3 gene expression precedes induction of haemoglobin-producing cells of the leukaemia K562 cell line treated with cis-diamminedichloroplatinum (II).
Marazzi L; Parodi MT; Di Martino D; Ferrari S; Tonini GP
Anticancer Res; 1991; 11(2):947-52. PubMed ID: 2064352
[TBL] [Abstract][Full Text] [Related]
10. Induction of differentiation in Friend-erythroleukemia cells by aclacinomycin A: early transient decrease in c-myc and c-myb mRNA levels.
Schaefer A; Dressel A; Lingelbach K; Schmidt CA; Steinheider G; Marquardt H
Leukemia; 1992 Aug; 6(8):828-33. PubMed ID: 1640736
[TBL] [Abstract][Full Text] [Related]
11. Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
Yamamoto-Yamaguchi Y; Makishima M; Kanatani Y; Kasukabe T; Honma Y
Exp Hematol; 1996 May; 24(6):682-9. PubMed ID: 8635523
[TBL] [Abstract][Full Text] [Related]
12. Hemin enhances the sensitivity of erythroleukemia cells to 1-beta-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity.
Honma Y; Onozuka Y; Okabe-Kado J; Kasukabe T; Hozumi M
Cancer Res; 1991 Sep; 51(17):4535-8. PubMed ID: 1873797
[TBL] [Abstract][Full Text] [Related]
13. Effects of tiazofurin on globin and proto-oncogene expression in K562 erythroleukemia cells.
Kharbanda SM; Miyazaki K; Takeyama H; Sherman ML; Spriggs DR; Carney WP; Kufe DW
Cancer Commun; 1989; 1(3):191-7. PubMed ID: 2639729
[TBL] [Abstract][Full Text] [Related]
14. Effects of 1-beta-D-arabinofuranosylcytosine on proto-oncogene expression in human U-937 cells.
Mitchell T; Sariban E; Kufe D
Mol Pharmacol; 1986 Oct; 30(4):398-402. PubMed ID: 3531806
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of erythroid differentiation by stem cell factor in K562 cells expressing the c-kit gene.
Ogawa K; Tashima M; Toi T; Sawai H; Sawada H; Fujita J; Maruyama Y; Okuma M
Exp Hematol; 1994 Jan; 22(1):45-51. PubMed ID: 7506674
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of c-myc gene is not obligatory for growth inhibition and differentiation of human myeloid leukemia cells.
Gómez-Casares MT; Delgado MD; Lerga A; Crespo P; Quincoces AF; Richard C; León J
Leukemia; 1993 Nov; 7(11):1824-33. PubMed ID: 8231250
[TBL] [Abstract][Full Text] [Related]
17. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells.
Bar-Ner M; Messing LT; Cultraro CM; Birrer MJ; Segal S
Cell Growth Differ; 1992 Mar; 3(3):183-90. PubMed ID: 1633109
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of a K562 cell line resistant to 1-beta-D-arabinofuranosylcytosine-mediated erythroid induction.
Biancha Scarrà G; Fiorentini P; Gambari R; Nastruzzi C; Barbieri R; Sessarego M; Ravazzolo R; Garrè C
Exp Hematol; 1989 Sep; 17(8):859-64. PubMed ID: 2475359
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of recombinant human leukemia inhibitory factor (LIF) and 1-beta-D-arabinofuranosylcytosine (Ara-C) on proto-oncogene expression and induction of differentiation in human U 937 cells.
Brach MA; Riedel D; Mertelsmann RH; Herrmann F
Leukemia; 1990 Sep; 4(9):646-9. PubMed ID: 2144331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]